_version_ 1785105831595868160
author Arlabosse, Tiphaine
Materna, Marie
Riccio, Orbicia
Schnider, Caroline
Angelini, Federica
Perreau, Matthieu
Rochat, Isabelle
Superti-Furga, Andrea
Campos-Xavier, Belinda
Héritier, Sébastien
Pereira, Anaïs
Deswarte, Caroline
Lévy, Romain
Distefano, Marco
Bustamante, Jacinta
Roelens, Marie
Borie, Raphaël
Le Brun, Mathilde
Crestani, Bruno
Casanova, Jean‑Laurent
Puel, Anne
Hofer, Michaël
Fieschi, Claire
Theodoropoulou, Katerina
Béziat, Vivien
Candotti, Fabio
author_facet Arlabosse, Tiphaine
Materna, Marie
Riccio, Orbicia
Schnider, Caroline
Angelini, Federica
Perreau, Matthieu
Rochat, Isabelle
Superti-Furga, Andrea
Campos-Xavier, Belinda
Héritier, Sébastien
Pereira, Anaïs
Deswarte, Caroline
Lévy, Romain
Distefano, Marco
Bustamante, Jacinta
Roelens, Marie
Borie, Raphaël
Le Brun, Mathilde
Crestani, Bruno
Casanova, Jean‑Laurent
Puel, Anne
Hofer, Michaël
Fieschi, Claire
Theodoropoulou, Katerina
Béziat, Vivien
Candotti, Fabio
author_sort Arlabosse, Tiphaine
collection PubMed
description
format Online
Article
Text
id pubmed-10499998
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-104999982023-09-15 Correction to: New Dominant‑Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130‑Dependent Hyper‑IgE Syndrome Arlabosse, Tiphaine Materna, Marie Riccio, Orbicia Schnider, Caroline Angelini, Federica Perreau, Matthieu Rochat, Isabelle Superti-Furga, Andrea Campos-Xavier, Belinda Héritier, Sébastien Pereira, Anaïs Deswarte, Caroline Lévy, Romain Distefano, Marco Bustamante, Jacinta Roelens, Marie Borie, Raphaël Le Brun, Mathilde Crestani, Bruno Casanova, Jean‑Laurent Puel, Anne Hofer, Michaël Fieschi, Claire Theodoropoulou, Katerina Béziat, Vivien Candotti, Fabio J Clin Immunol Correction Springer US 2023-06-21 2023 /pmc/articles/PMC10499998/ /pubmed/37341861 http://dx.doi.org/10.1007/s10875-023-01539-y Text en © Springer Science+Business Media, LLC, part of Springer Nature 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Arlabosse, Tiphaine
Materna, Marie
Riccio, Orbicia
Schnider, Caroline
Angelini, Federica
Perreau, Matthieu
Rochat, Isabelle
Superti-Furga, Andrea
Campos-Xavier, Belinda
Héritier, Sébastien
Pereira, Anaïs
Deswarte, Caroline
Lévy, Romain
Distefano, Marco
Bustamante, Jacinta
Roelens, Marie
Borie, Raphaël
Le Brun, Mathilde
Crestani, Bruno
Casanova, Jean‑Laurent
Puel, Anne
Hofer, Michaël
Fieschi, Claire
Theodoropoulou, Katerina
Béziat, Vivien
Candotti, Fabio
Correction to: New Dominant‑Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130‑Dependent Hyper‑IgE Syndrome
title Correction to: New Dominant‑Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130‑Dependent Hyper‑IgE Syndrome
title_full Correction to: New Dominant‑Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130‑Dependent Hyper‑IgE Syndrome
title_fullStr Correction to: New Dominant‑Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130‑Dependent Hyper‑IgE Syndrome
title_full_unstemmed Correction to: New Dominant‑Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130‑Dependent Hyper‑IgE Syndrome
title_short Correction to: New Dominant‑Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130‑Dependent Hyper‑IgE Syndrome
title_sort correction to: new dominant‑negative il6st variants expand the immunological and clinical spectrum of gp130‑dependent hyper‑ige syndrome
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499998/
https://www.ncbi.nlm.nih.gov/pubmed/37341861
http://dx.doi.org/10.1007/s10875-023-01539-y
work_keys_str_mv AT arlabossetiphaine correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT maternamarie correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT riccioorbicia correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT schnidercaroline correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT angelinifederica correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT perreaumatthieu correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT rochatisabelle correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT supertifurgaandrea correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT camposxavierbelinda correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT heritiersebastien correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT pereiraanais correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT deswartecaroline correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT levyromain correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT distefanomarco correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT bustamantejacinta correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT roelensmarie correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT borieraphael correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT lebrunmathilde correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT crestanibruno correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT casanovajeanlaurent correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT puelanne correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT hofermichael correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT fieschiclaire correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT theodoropouloukaterina correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT beziatvivien correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome
AT candottifabio correctiontonewdominantnegativeil6stvariantsexpandtheimmunologicalandclinicalspectrumofgp130dependenthyperigesyndrome